Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less ToxicityImke H. Bartelink, Jaap Jan Boelens, Elisabeth M L van Reij et al.|Transplantation and Cellular Therapy|2013Cited by 110
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumorsImke H. Bartelink, Laura van ‘t Veer, Brendan Prideaux et al.|Breast Cancer Research|2017Cited by 24
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunityTim Bognàr, Imke H. Bartelink, Toine C. G. Egberts et al.|Blood Advances|2024Cited by 13
Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimenTim Bognàr, Arief Lalmohamed, Jurjen S. Kingma et al.|Bone Marrow Transplantation|2023Cited by 11
Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen.Tim Bognàr, Arief Lalmohammed, Jurjen S. Kingma et al.|Research Square|2023Cited by 6